You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CEL

Showing 1 - 25 of 255
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CAR-T Retreatment Trial in Shanghai (axi-cel)

Recruiting
  • CAR-T Retreatment
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Mar 23, 2023

Systemic Lupus Erythematosus Trial in Shanghai (Relma-cel)

Recruiting
  • Systemic Lupus Erythematosus
  • Relma-cel
  • Shanghai, China
    Relma-cel Medical
Mar 12, 2023

Non-Hodgkin Lymphoma, Large B-cell Lymphoma Trial in Palo Alto (Axicabtagene Ciloleucel)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • Large B-cell Lymphoma
  • Axicabtagene Ciloleucel
  • Palo Alto, California
    Stanford University
Mar 20, 2023

Sickle Cell Disease Trial (Exa-cel)

Not yet recruiting
  • Sickle Cell Disease
  • Exa-cel
  • (no location specified)
Jul 14, 2023

Anal Fistula Trial in New York (E-CEL UVEC)

Recruiting
  • Anal Fistula
  • E-CEL UVEC
  • New York, New York
    Weill Cornell Medical College - NewYork-Presbyterian Hospital
Jan 18, 2023

Healthy Trial in Lincoln (CEL383, Placebo)

Recruiting
  • Healthy
  • Lincoln, Nebraska
    Celerion
Jun 5, 2023

Multiple Myeloma Trial (Cilta-cel OOS Therapy)

Available
  • Multiple Myeloma
  • Cilta-cel OOS Therapy
  • (no location specified)
Aug 15, 2022

Lymphoma, Lymphoma Cns Trial in Boston (Fludarabine, Cyclophosphamide, Axicabtagene Ciloleucel)

Recruiting
  • Lymphoma
  • Lymphoma Cns
  • Boston, Massachusetts
  • +1 more
Jan 3, 2023

Multiple Myeloma Trial in New York (Ide-cel (bb2121))

Recruiting
  • Multiple Myeloma
  • Ide-cel (bb2121)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 6, 2022

Rotator Cuff Tears, Muscle Atrophy or Weakness, Tendon Rupture - Shoulder Trial in New York (E-CEL UVEC)

Active, not recruiting
  • Rotator Cuff Tears
  • +3 more
  • E-CEL UVEC
  • New York, New York
    Hospital for Special Surgery
Aug 5, 2022

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor(CAR) T Cells)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Diffuse Large B Cell Lymphoma
  • CD19-targeted Chimeric Antigen Receptor(CAR) T Cells
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital
Nov 19, 2023

Tumors Trial in Worldwide (Letetresgene autoleucel)

Active, not recruiting
  • Neoplasms
  • Letetresgene autoleucel
  • Pittsburgh, Pennsylvania
  • +5 more
Aug 7, 2023

Multiple Myeloma, Smoldering Multiple Myeloma Trial in Boston (Ciltacabtagene Autoleucel, Cyclophosphamide, Fludarabine

Not yet recruiting
  • Multiple Myeloma
  • Smoldering Multiple Myeloma
  • Ciltacabtagene Autoleucel
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 2, 2023

Diffuse Large B Cell Lymphoma Trial in Tampa (Itacitinib, Chimeric antigen receptor (CAR) T-cell therapy)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Itacitinib
  • Chimeric antigen receptor (CAR) T-cell therapy
  • Tampa, Florida
    Moffitt Cancer Center
Mar 6, 2023

Aging Trial in Salt Lake City (SRW Cel System)

Recruiting
  • Aging
  • SRW Cel System
  • Salt Lake City, Utah
    Regenerative Wellness Center
Sep 9, 2022

Extramedullary Myeloma Trial in Melbourne (Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent)

Not yet recruiting
  • Extramedullary Myeloma
  • Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Dec 18, 2022

High-risk Large B-cell Lymphoma (LBCL) Trial (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • High-risk Large B-cell Lymphoma (LBCL)
  • Axicabtagene Ciloleucel
  • +7 more
  • (no location specified)
Dec 13, 2022

Lymphoma Trial in Minneapolis (Simvastatin, Dexamethasone)

Recruiting
  • Lymphoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Aug 23, 2021

Multiple Myeloma Trial in Spain, United States (BB2121, CC-220, BMS-986405)

Recruiting
  • Multiple Myeloma
  • BB2121
  • +2 more
  • Birmingham, Alabama
  • +33 more
Jan 26, 2023

Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Tampa (Comprehensive Ablative Bridging Irradiation (CABI),

Recruiting
  • Large B-cell Lymphoma
  • Relapsed Non-Hodgkin Lymphoma
  • Comprehensive Ablative Bridging Irradiation (CABI)
  • Chimeric Antigen Receptor T-Cell Therapy
  • Tampa, Florida
    Moffitt Cancer Center
Oct 26, 2023

Cerebral Adrenoleukodystrophy (CALD) Trial in Worldwide (Lenti-D Drug Product (eli-cel))

Completed
Has Results
  • Cerebral Adrenoleukodystrophy (CALD)
  • Lenti-D Drug Product (eli-cel)
  • Los Angeles, California
  • +7 more
Mar 25, 2022

SARS-CoV-2 Immune Surveillance AmongPopulation Based Sample of

Completed
  • Coronavirus Infection
  • SARS-CoV-2 Antibody Analysis
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Sep 30, 2022

B-cell Lymphoma Trial in Beijing (Relmacabtagene Autoleucel, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • B-cell Lymphoma
  • Relmacabtagene Autoleucel
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Oct 19, 2022

DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Trial (Bridging radiation therapy,

Not yet recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • +6 more
  • Bridging radiation therapy
  • +2 more
  • (no location specified)
Jan 4, 2023

Non Hodgkin's Lymphoma Trial in China (Chidamide, Fludarabine and cyclophosphamide, Anti-CD19 CAR-T cells)

Recruiting
  • Non Hodgkin's Lymphoma
  • Beijing, Beijing, China
  • +12 more
Jun 9, 2022